A Study of LY3493269 in Healthy Participants

NCT04682106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3493269
DRUG: Placebo
DRUG: Salcaprozate Sodium

Sponsor

Eli Lilly and Company